Braidwell »

Bioage Labs shares owned by Braidwell

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 1.2M 17.49

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding Bioage Labs

AH Capital Management
Cormorant Asset Management
Sofinnova Ventures
BlackRock
Henderson Group
Octagon Capital Advisors
RA Capital Management
Vanguard Group
Vanguard Capital Management
Balyasny Asset Management
Braidwell
Adage Capital Partners GP
Sands Capital Ventures
Geode Capital Management
OrbiMed Advisors

View all funds holding Bioage Labs